Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.77
+0.24 (0.72%)
Jul 17, 2026, 4:00 PM EDT - Market closed
HRMY Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $44.91. The average 1-year stock price forecast is 32.99% higher than the current stock price, while the lowest is $28 (-17.09%) and the highest is $85 (+151.70%).
Price Target: $44.91 (+32.99%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $37 | Hold | Maintains | $37 | +9.56% | Jul 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $55 | Buy | Reiterates | $55 | +62.87% | Jul 16, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $50 | Buy | Maintains | $50 | +48.06% | Jul 16, 2026 |
| Needham | Needham | Buy Maintains $45 | Buy | Maintains | $45 | +33.25% | Jul 16, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $30 → $36 | Hold | Maintains | $30 → $36 | +6.60% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
1.01B
from 868.45M
Increased by 16.82%
Revenue Next Year
1.16B
from 1.01B
Increased by 14.07%
EPS This Year
4.50
from 3.60
Increased by 24.94%
EPS Next Year
6.02
from 4.50
Increased by 33.83%
EPS and Forward PE are based on non-GAAP adjusted numbers.